BAM
CHE icon

Belpointe Asset Management’s Chemed CHE Stock Holding History

Belpointe Asset Management’s Portfolio CHE Stock Details CHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-595
Closed -$382K – 863
2024
Q1 		$382K Buy
+595
New +$361K 0.03% 512
2023
Q2 		– Sell
-205
Closed -$110K – 1045
2023
Q1 		$110K Buy
205
+88
+75% +$44.9K 0.01% 1247
2022
Q4 		$59.7K Buy
+117
New +$57K ﹤0.01% 1502

Other funds holding CHE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return

Belpointe Asset Management's CHE Position: Q2 2024 in Review

Belpointe Asset Management sold out of Chemed (CHE) in Q2 2024, closing a stake of 595 shares — an estimated $382K sold.

Belpointe Asset Management first reported a position in CHE in Q4 2022 and held it in 3 quarters. The position peaked at $382K in Q1 2024. 513 funds tracked by Wall St. Rank hold CHE as of Q2 2024.

  • Belpointe Asset Management reported no remaining Chemed position as of Q2 2024 after selling out during the quarter.
  • Belpointe Asset Management sold 595 Chemed shares in Q2 2024, an estimated $382K.
  • Belpointe Asset Management first reported a position in Chemed in Q4 2022 and held it in 3 quarters.
  • Belpointe Asset Management's Chemed position peaked at $382K in Q1 2024.
  • 513 funds tracked by Wall St. Rank held Chemed as of Q2 2024.

Based on Belpointe Asset Management's 13F filing for Q2 2024, filed 2 Aug 2024.